Exelixis, Inc. (EXEL)
NASDAQ: EXEL · IEX Real-Time Price · USD
21.69
+0.91 (4.38%)
At close: May 31, 2024, 4:00 PM
21.72
+0.03 (0.14%)
After-hours: May 31, 2024, 6:47 PM EDT
Exelixis Employees
Exelixis had 1,310 employees on December 31, 2023. The number of employees increased by 87 or 7.11% compared to the previous year.
Employees
1,310
Change (1Y)
87
Growth (1Y)
7.11%
Revenue / Employee
$1,409,653
Profits / Employee
$156,530
Market Cap
6.32B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,310 | 87 | 7.11% |
Dec 31, 2022 | 1,223 | 269 | 28.20% |
Dec 31, 2021 | 954 | 181 | 23.42% |
Dec 31, 2020 | 773 | 156 | 25.28% |
Dec 31, 2019 | 617 | 133 | 27.48% |
Dec 31, 2018 | 484 | 112 | 30.11% |
Dec 31, 2017 | 372 | 85 | 29.62% |
Dec 31, 2016 | 287 | 172 | 149.57% |
Dec 31, 2015 | 115 | 17 | 17.35% |
Dec 31, 2014 | 98 | -129 | -56.83% |
Dec 31, 2013 | 227 | 53 | 30.46% |
Dec 31, 2012 | 174 | -26 | -13.00% |
Dec 31, 2011 | 200 | -183 | -47.78% |
Dec 31, 2010 | 383 | -293 | -43.34% |
Dec 31, 2009 | 676 | 0 | - |
Dec 31, 2008 | 676 | -59 | -8.03% |
Dec 31, 2007 | 735 | 84 | 12.90% |
Dec 31, 2006 | 651 | 101 | 18.36% |
Dec 31, 2005 | 550 | 33 | 6.38% |
Dec 31, 2004 | 517 | -56 | -9.77% |
Dec 31, 2003 | 573 | 23 | 4.18% |
Dec 31, 2002 | 550 | -21 | -3.68% |
Dec 31, 2001 | 571 | 214 | 59.94% |
Dec 31, 2000 | 357 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Grifols | 23,737 |
Acadia Healthcare Company | 23,500 |
DENTSPLY SIRONA | 15,000 |
Masimo | 3,800 |
Jazz Pharmaceuticals | 2,800 |
Glaukos | 907 |
Lantheus Holdings | 834 |
Blueprint Medicines | 655 |
EXEL News
- 5 days ago - Exelixis to Present at the William Blair 44th Annual Growth Stock Conference - Business Wire
- 13 days ago - Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA - Business Wire
- 26 days ago - Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May - Business Wire
- 4 weeks ago - Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update - Business Wire
- 6 weeks ago - Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024 - Business Wire
- 3 months ago - Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March - Business Wire
- 3 months ago - Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments - GuruFocus
- 4 months ago - Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update - Business Wire